Is Multiple System Atrophy a Prion-like Disorder?

Area of Science:

• Neurodegenerative diseases
• Prion biology
• α-synucleinopathies

Background:

• Multiple system atrophy (MSA) is a fatal, rapidly progressing neurodegenerative disorder.
• MSA is characterized by parkinsonism, cerebellar, autonomic, and motor impairments.
• Pathologically, MSA features glial cytoplasmic inclusions (GCIs) rich in α-synuclein (αSyn).

Purpose of the Study:

• To discuss the evidence for and against classifying MSA as a prion disease.
• To explore the self-propagation and transmissibility of αSyn pathology.
• To clarify the debate surrounding the terminology of αSyn in neurodegeneration.

Main Methods:

• Review of existing scientific literature on MSA, αSyn, and prion diseases.
• Analysis of findings from animal models and in vitro studies.
• Comparison of αSyn pathology in MSA with other synucleinopathies like Parkinson's disease.

Main Results:

• MSA pathology shares similarities with prion propagation, including potential seeding mechanisms.
• Animal models have shown limited success in replicating human MSA pathology.
• Transmission of αSyn pathology from MSA to non-human primates has not been reported.

Conclusions:

• Despite similarities to prion diseases, conclusive evidence for MSA as a human prion disease is lacking.
• The molecular mechanisms of αSyn self-propagation and transmission require further investigation.
• The classification of MSA and its αSyn pathology remains an area of active debate.